nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—ALB—hepatitis B	0.404	1	CbGaD
Vemurafenib—ABCC1—Lamivudine—hepatitis B	0.212	0.599	CbGbCtD
Vemurafenib—ABCG2—Lamivudine—hepatitis B	0.142	0.401	CbGbCtD
Vemurafenib—ORM1—saliva—hepatitis B	0.00683	0.262	CbGeAlD
Vemurafenib—Musculoskeletal pain—Telbivudine—hepatitis B	0.00326	0.0294	CcSEcCtD
Vemurafenib—Folliculitis—Lamivudine—hepatitis B	0.00289	0.026	CcSEcCtD
Vemurafenib—BRAF—blood—hepatitis B	0.00237	0.091	CbGeAlD
Vemurafenib—Pain in extremity—Telbivudine—hepatitis B	0.00234	0.0211	CcSEcCtD
Vemurafenib—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00217	0.0196	CcSEcCtD
Vemurafenib—Oedema peripheral—Entecavir—hepatitis B	0.00194	0.0175	CcSEcCtD
Vemurafenib—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00189	0.017	CcSEcCtD
Vemurafenib—Vasculitis—Lamivudine—hepatitis B	0.00186	0.0167	CcSEcCtD
Vemurafenib—BRAF—liver—hepatitis B	0.00185	0.0712	CbGeAlD
Vemurafenib—Musculoskeletal pain—Lamivudine—hepatitis B	0.00184	0.0165	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Telbivudine—hepatitis B	0.00177	0.0159	CcSEcCtD
Vemurafenib—Alopecia—Entecavir—hepatitis B	0.00174	0.0157	CcSEcCtD
Vemurafenib—CYP1A2—blood plasma—hepatitis B	0.00172	0.0659	CbGeAlD
Vemurafenib—Malnutrition—Entecavir—hepatitis B	0.00171	0.0154	CcSEcCtD
Vemurafenib—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00167	0.0151	CcSEcCtD
Vemurafenib—Back pain—Adefovir Dipivoxil—hepatitis B	0.00162	0.0146	CcSEcCtD
Vemurafenib—Connective tissue disorder—Telbivudine—hepatitis B	0.00159	0.0143	CcSEcCtD
Vemurafenib—RAF1—blood—hepatitis B	0.00158	0.0606	CbGeAlD
Vemurafenib—Cough—Adefovir Dipivoxil—hepatitis B	0.00146	0.0131	CcSEcCtD
Vemurafenib—Mediastinal disorder—Telbivudine—hepatitis B	0.00146	0.0131	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00145	0.013	CcSEcCtD
Vemurafenib—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00142	0.0128	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00141	0.0127	CcSEcCtD
Vemurafenib—Malnutrition—Telbivudine—hepatitis B	0.00141	0.0127	CcSEcCtD
Vemurafenib—Anaphylactic shock—Entecavir—hepatitis B	0.0014	0.0126	CcSEcCtD
Vemurafenib—Infection—Entecavir—hepatitis B	0.00139	0.0125	CcSEcCtD
Vemurafenib—Dysgeusia—Telbivudine—hepatitis B	0.00138	0.0124	CcSEcCtD
Vemurafenib—Nervous system disorder—Entecavir—hepatitis B	0.00137	0.0124	CcSEcCtD
Vemurafenib—Back pain—Telbivudine—hepatitis B	0.00136	0.0123	CcSEcCtD
Vemurafenib—Skin disorder—Entecavir—hepatitis B	0.00136	0.0122	CcSEcCtD
Vemurafenib—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00134	0.0121	CcSEcCtD
Vemurafenib—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00133	0.0119	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00124	0.0112	CcSEcCtD
Vemurafenib—CYP3A4—blood plasma—hepatitis B	0.00124	0.0477	CbGeAlD
Vemurafenib—RAF1—liver—hepatitis B	0.00123	0.0474	CbGeAlD
Vemurafenib—Cough—Telbivudine—hepatitis B	0.00123	0.0111	CcSEcCtD
Vemurafenib—CYP2D6—blood plasma—hepatitis B	0.00122	0.0469	CbGeAlD
Vemurafenib—Gastrointestinal disorder—Entecavir—hepatitis B	0.00121	0.0109	CcSEcCtD
Vemurafenib—Fatigue—Entecavir—hepatitis B	0.00121	0.0109	CcSEcCtD
Vemurafenib—Arthralgia—Telbivudine—hepatitis B	0.0012	0.0108	CcSEcCtD
Vemurafenib—Myalgia—Telbivudine—hepatitis B	0.0012	0.0108	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00119	0.0107	CcSEcCtD
Vemurafenib—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00119	0.0107	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00118	0.0106	CcSEcCtD
Vemurafenib—Nervous system disorder—Telbivudine—hepatitis B	0.00113	0.0101	CcSEcCtD
Vemurafenib—Skin disorder—Telbivudine—hepatitis B	0.00112	0.0101	CcSEcCtD
Vemurafenib—Body temperature increased—Entecavir—hepatitis B	0.00111	0.00996	CcSEcCtD
Vemurafenib—ORM1—blood—hepatitis B	0.00109	0.0419	CbGeAlD
Vemurafenib—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00108	0.00972	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00105	0.00943	CcSEcCtD
Vemurafenib—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00101	0.00907	CcSEcCtD
Vemurafenib—Asthenia—Entecavir—hepatitis B	0.001	0.00904	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Lamivudine—hepatitis B	0.000995	0.00896	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Telbivudine—hepatitis B	0.000992	0.00893	CcSEcCtD
Vemurafenib—Fatigue—Telbivudine—hepatitis B	0.00099	0.00892	CcSEcCtD
Vemurafenib—Asthenia—Adefovir Dipivoxil—hepatitis B	0.000979	0.00882	CcSEcCtD
Vemurafenib—Pruritus—Adefovir Dipivoxil—hepatitis B	0.000965	0.0087	CcSEcCtD
Vemurafenib—Diarrhoea—Entecavir—hepatitis B	0.000957	0.00862	CcSEcCtD
Vemurafenib—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000933	0.00841	CcSEcCtD
Vemurafenib—Dizziness—Entecavir—hepatitis B	0.000925	0.00833	CcSEcCtD
Vemurafenib—Body temperature increased—Telbivudine—hepatitis B	0.000908	0.00818	CcSEcCtD
Vemurafenib—Connective tissue disorder—Lamivudine—hepatitis B	0.000895	0.00807	CcSEcCtD
Vemurafenib—Vomiting—Entecavir—hepatitis B	0.000889	0.00801	CcSEcCtD
Vemurafenib—Rash—Entecavir—hepatitis B	0.000882	0.00794	CcSEcCtD
Vemurafenib—Dermatitis—Entecavir—hepatitis B	0.000881	0.00794	CcSEcCtD
Vemurafenib—Headache—Entecavir—hepatitis B	0.000876	0.00789	CcSEcCtD
Vemurafenib—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000867	0.00781	CcSEcCtD
Vemurafenib—Erythema multiforme—Lamivudine—hepatitis B	0.000862	0.00776	CcSEcCtD
Vemurafenib—Rash—Adefovir Dipivoxil—hepatitis B	0.00086	0.00775	CcSEcCtD
Vemurafenib—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000859	0.00774	CcSEcCtD
Vemurafenib—Headache—Adefovir Dipivoxil—hepatitis B	0.000855	0.0077	CcSEcCtD
Vemurafenib—ORM1—liver—hepatitis B	0.000852	0.0327	CbGeAlD
Vemurafenib—Nausea—Entecavir—hepatitis B	0.000831	0.00748	CcSEcCtD
Vemurafenib—Asthenia—Telbivudine—hepatitis B	0.000824	0.00742	CcSEcCtD
Vemurafenib—Mediastinal disorder—Lamivudine—hepatitis B	0.000821	0.0074	CcSEcCtD
Vemurafenib—Chills—Lamivudine—hepatitis B	0.000818	0.00737	CcSEcCtD
Vemurafenib—Pruritus—Telbivudine—hepatitis B	0.000813	0.00732	CcSEcCtD
Vemurafenib—Nausea—Adefovir Dipivoxil—hepatitis B	0.00081	0.0073	CcSEcCtD
Vemurafenib—Alopecia—Lamivudine—hepatitis B	0.000805	0.00725	CcSEcCtD
Vemurafenib—Erythema—Lamivudine—hepatitis B	0.000793	0.00715	CcSEcCtD
Vemurafenib—Malnutrition—Lamivudine—hepatitis B	0.000793	0.00715	CcSEcCtD
Vemurafenib—ABCC1—blood—hepatitis B	0.000789	0.0303	CbGeAlD
Vemurafenib—Diarrhoea—Telbivudine—hepatitis B	0.000786	0.00708	CcSEcCtD
Vemurafenib—Dysgeusia—Lamivudine—hepatitis B	0.000777	0.007	CcSEcCtD
Vemurafenib—Back pain—Lamivudine—hepatitis B	0.000767	0.00691	CcSEcCtD
Vemurafenib—Dizziness—Telbivudine—hepatitis B	0.00076	0.00684	CcSEcCtD
Vemurafenib—ALB—liver—hepatitis B	0.000747	0.0287	CbGeAlD
Vemurafenib—Vomiting—Telbivudine—hepatitis B	0.00073	0.00658	CcSEcCtD
Vemurafenib—Rash—Telbivudine—hepatitis B	0.000724	0.00652	CcSEcCtD
Vemurafenib—Dermatitis—Telbivudine—hepatitis B	0.000724	0.00652	CcSEcCtD
Vemurafenib—Headache—Telbivudine—hepatitis B	0.00072	0.00648	CcSEcCtD
Vemurafenib—Cough—Lamivudine—hepatitis B	0.000692	0.00624	CcSEcCtD
Vemurafenib—Nausea—Telbivudine—hepatitis B	0.000682	0.00615	CcSEcCtD
Vemurafenib—Arthralgia—Lamivudine—hepatitis B	0.000675	0.00608	CcSEcCtD
Vemurafenib—Myalgia—Lamivudine—hepatitis B	0.000675	0.00608	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000671	0.00604	CcSEcCtD
Vemurafenib—ABCG2—blood—hepatitis B	0.000653	0.0251	CbGeAlD
Vemurafenib—Anaphylactic shock—Lamivudine—hepatitis B	0.000647	0.00583	CcSEcCtD
Vemurafenib—Infection—Lamivudine—hepatitis B	0.000643	0.00579	CcSEcCtD
Vemurafenib—Nervous system disorder—Lamivudine—hepatitis B	0.000635	0.00572	CcSEcCtD
Vemurafenib—Skin disorder—Lamivudine—hepatitis B	0.000629	0.00566	CcSEcCtD
Vemurafenib—CYP1A2—blood—hepatitis B	0.000628	0.0241	CbGeAlD
Vemurafenib—ABCC1—liver—hepatitis B	0.000617	0.0237	CbGeAlD
Vemurafenib—Hypotension—Lamivudine—hepatitis B	0.000605	0.00545	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00059	0.00531	CcSEcCtD
Vemurafenib—Decreased appetite—Lamivudine—hepatitis B	0.000563	0.00507	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000559	0.00503	CcSEcCtD
Vemurafenib—Fatigue—Lamivudine—hepatitis B	0.000558	0.00503	CcSEcCtD
Vemurafenib—Constipation—Lamivudine—hepatitis B	0.000554	0.00499	CcSEcCtD
Vemurafenib—Body temperature increased—Lamivudine—hepatitis B	0.000512	0.00461	CcSEcCtD
Vemurafenib—ABCG2—liver—hepatitis B	0.000511	0.0196	CbGeAlD
Vemurafenib—CYP1A2—liver—hepatitis B	0.000491	0.0189	CbGeAlD
Vemurafenib—Hypersensitivity—Lamivudine—hepatitis B	0.000477	0.0043	CcSEcCtD
Vemurafenib—Asthenia—Lamivudine—hepatitis B	0.000464	0.00418	CcSEcCtD
Vemurafenib—Pruritus—Lamivudine—hepatitis B	0.000458	0.00413	CcSEcCtD
Vemurafenib—CYP3A4—blood—hepatitis B	0.000455	0.0175	CbGeAlD
Vemurafenib—CYP2D6—blood—hepatitis B	0.000448	0.0172	CbGeAlD
Vemurafenib—Diarrhoea—Lamivudine—hepatitis B	0.000443	0.00399	CcSEcCtD
Vemurafenib—Dizziness—Lamivudine—hepatitis B	0.000428	0.00386	CcSEcCtD
Vemurafenib—Vomiting—Lamivudine—hepatitis B	0.000412	0.00371	CcSEcCtD
Vemurafenib—Rash—Lamivudine—hepatitis B	0.000408	0.00368	CcSEcCtD
Vemurafenib—Dermatitis—Lamivudine—hepatitis B	0.000408	0.00367	CcSEcCtD
Vemurafenib—Headache—Lamivudine—hepatitis B	0.000406	0.00365	CcSEcCtD
Vemurafenib—Nausea—Lamivudine—hepatitis B	0.000385	0.00346	CcSEcCtD
Vemurafenib—CYP3A4—liver—hepatitis B	0.000356	0.0137	CbGeAlD
Vemurafenib—CYP2D6—liver—hepatitis B	0.00035	0.0134	CbGeAlD
Vemurafenib—BRAF—Signaling by NGF—NFKB1—hepatitis B	7.76e-05	0.000744	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—PTEN—hepatitis B	7.74e-05	0.000743	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—CTNNB1—hepatitis B	7.68e-05	0.000736	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR—IL6—hepatitis B	7.67e-05	0.000736	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	7.64e-05	0.000733	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	7.6e-05	0.000729	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—GGT1—hepatitis B	7.51e-05	0.000721	CbGpPWpGaD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—IL6—hepatitis B	7.51e-05	0.000721	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—PTEN—hepatitis B	7.48e-05	0.000718	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	7.47e-05	0.000716	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—AKR1B1—hepatitis B	7.46e-05	0.000716	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—MX1—hepatitis B	7.46e-05	0.000716	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	7.45e-05	0.000715	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	7.43e-05	0.000713	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—NFKB1—hepatitis B	7.42e-05	0.000712	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	7.41e-05	0.000711	CbGpPWpGaD
Vemurafenib—RAF1—VEGFA-VEGFR2 Pathway—IL6—hepatitis B	7.4e-05	0.00071	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—IFNA2—hepatitis B	7.36e-05	0.000706	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CD14—hepatitis B	7.36e-05	0.000706	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Interleukins—IL6—hepatitis B	7.34e-05	0.000705	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—TNF—hepatitis B	7.26e-05	0.000697	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	7.26e-05	0.000697	CbGpPWpGaD
Vemurafenib—ALB—Vitamin B12 Metabolism—IL6—hepatitis B	7.2e-05	0.000691	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GGT2—hepatitis B	7.15e-05	0.000686	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR in disease—IL6—hepatitis B	7.15e-05	0.000686	CbGpPWpGaD
Vemurafenib—RAF1—Platelet activation, signaling and aggregation—IL2—hepatitis B	7.05e-05	0.000676	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—CDKN1A—hepatitis B	7.03e-05	0.000674	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—PTEN—hepatitis B	7.01e-05	0.000673	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by VEGF—IL6—hepatitis B	6.98e-05	0.00067	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SAG—hepatitis B	6.96e-05	0.000668	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—RIT2—hepatitis B	6.96e-05	0.000668	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Insulin receptor—IL6—hepatitis B	6.94e-05	0.000665	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—TGFB1—hepatitis B	6.84e-05	0.000657	CbGpPWpGaD
Vemurafenib—RAF1—TGF-beta Signaling Pathway—TP53—hepatitis B	6.83e-05	0.000656	CbGpPWpGaD
Vemurafenib—BRAF—Disease—GOT2—hepatitis B	6.82e-05	0.000655	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	6.78e-05	0.000651	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	6.78e-05	0.000651	CbGpPWpGaD
Vemurafenib—ALB—Platelet degranulation—TGFB1—hepatitis B	6.67e-05	0.00064	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—AKR1B1—hepatitis B	6.57e-05	0.00063	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—IFNG—hepatitis B	6.56e-05	0.000629	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—TP53—hepatitis B	6.4e-05	0.000614	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—TNF—hepatitis B	6.39e-05	0.000613	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	6.36e-05	0.000611	CbGpPWpGaD
Vemurafenib—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—hepatitis B	6.35e-05	0.000609	CbGpPWpGaD
Vemurafenib—BRAF—NGF signalling via TRKA from the plasma membrane—IL6—hepatitis B	6.33e-05	0.000607	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GGT2—hepatitis B	6.3e-05	0.000604	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	6.18e-05	0.000593	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD40LG—hepatitis B	6.01e-05	0.000576	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD8A—hepatitis B	5.94e-05	0.00057	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—IL6—hepatitis B	5.93e-05	0.000569	CbGpPWpGaD
Vemurafenib—BRAF—Disease—GOT1—hepatitis B	5.89e-05	0.000565	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—IL6—hepatitis B	5.86e-05	0.000562	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—IL2—hepatitis B	5.83e-05	0.000559	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—GGT1—hepatitis B	5.8e-05	0.000556	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—TNF—hepatitis B	5.77e-05	0.000554	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	5.77e-05	0.000553	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—IL6—hepatitis B	5.68e-05	0.000545	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—TP53—hepatitis B	5.63e-05	0.00054	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—F2—hepatitis B	5.63e-05	0.00054	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—IL6—hepatitis B	5.59e-05	0.000536	CbGpPWpGaD
Vemurafenib—RAF1—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	5.5e-05	0.000527	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—NFKB1—hepatitis B	5.46e-05	0.000524	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—CDKN1A—hepatitis B	5.41e-05	0.000519	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—PTEN—hepatitis B	5.39e-05	0.000517	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—F2—hepatitis B	5.39e-05	0.000517	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—HSPA5—hepatitis B	5.37e-05	0.000515	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—NFKB1—hepatitis B	5.37e-05	0.000515	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—IL6—hepatitis B	5.34e-05	0.000512	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—NOS2—hepatitis B	5.33e-05	0.000511	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—IL6—hepatitis B	5.31e-05	0.000509	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—HLA-A—hepatitis B	5.3e-05	0.000508	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—IL6—hepatitis B	5.28e-05	0.000507	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—IL6—hepatitis B	5.26e-05	0.000504	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HSPA5—hepatitis B	5.23e-05	0.000502	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	5.08e-05	0.000488	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—TLR4—hepatitis B	5.04e-05	0.000484	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—IL6—hepatitis B	4.95e-05	0.000475	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—IL6—hepatitis B	4.95e-05	0.000475	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—IL6—hepatitis B	4.95e-05	0.000475	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HLA-DPB1—hepatitis B	4.94e-05	0.000474	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—IL6—hepatitis B	4.9e-05	0.00047	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—IL6—hepatitis B	4.87e-05	0.000467	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—IL6—hepatitis B	4.86e-05	0.000466	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—IFNB1—hepatitis B	4.84e-05	0.000465	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—HLA-DRB1—hepatitis B	4.84e-05	0.000464	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—IL6—hepatitis B	4.84e-05	0.000464	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—TLR2—hepatitis B	4.75e-05	0.000456	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—IFNA1—hepatitis B	4.73e-05	0.000453	CbGpPWpGaD
Vemurafenib—RAF1—Disease—GOT2—hepatitis B	4.72e-05	0.000453	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IFNB1—hepatitis B	4.72e-05	0.000453	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—GOT2—hepatitis B	4.68e-05	0.000449	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—IL6—hepatitis B	4.66e-05	0.000447	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CXCL10—hepatitis B	4.65e-05	0.000446	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IFNA1—hepatitis B	4.6e-05	0.000442	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—ALB—hepatitis B	4.48e-05	0.00043	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—IFNA2—hepatitis B	4.4e-05	0.000422	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CCR5—hepatitis B	4.4e-05	0.000422	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—IL6—hepatitis B	4.38e-05	0.00042	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CYP2A6—hepatitis B	4.33e-05	0.000416	CbGpPWpGaD
Vemurafenib—BRAF—Disease—HLA-A—hepatitis B	4.29e-05	0.000411	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IFNA2—hepatitis B	4.29e-05	0.000411	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD14—hepatitis B	4.29e-05	0.000411	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	4.23e-05	0.000406	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	4.13e-05	0.000396	CbGpPWpGaD
Vemurafenib—RAF1—Disease—GOT1—hepatitis B	4.08e-05	0.000391	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—AKR1B1—hepatitis B	4.05e-05	0.000389	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	4.04e-05	0.000388	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—GOT1—hepatitis B	4.04e-05	0.000388	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CXCL10—hepatitis B	3.97e-05	0.000381	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GOT2—hepatitis B	3.92e-05	0.000376	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GGT2—hepatitis B	3.88e-05	0.000373	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—ALB—hepatitis B	3.88e-05	0.000372	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—ALB—hepatitis B	3.84e-05	0.000369	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CYP2A6—hepatitis B	3.81e-05	0.000366	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—IL2—hepatitis B	3.79e-05	0.000364	CbGpPWpGaD
Vemurafenib—BRAF—Disease—NOS2—hepatitis B	3.73e-05	0.000358	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL18—hepatitis B	3.66e-05	0.000351	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD40LG—hepatitis B	3.64e-05	0.00035	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—IL2—hepatitis B	3.63e-05	0.000348	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CCR5—hepatitis B	3.61e-05	0.000346	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD8A—hepatitis B	3.6e-05	0.000346	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—CTNNB1—hepatitis B	3.57e-05	0.000343	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CD4—hepatitis B	3.55e-05	0.000341	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—NFKB1—hepatitis B	3.47e-05	0.000333	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GOT2—hepatitis B	3.45e-05	0.000331	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—IL6—hepatitis B	3.43e-05	0.000329	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD4—hepatitis B	3.41e-05	0.000327	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GGT1—hepatitis B	3.38e-05	0.000325	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GOT1—hepatitis B	3.38e-05	0.000325	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—ALB—hepatitis B	3.38e-05	0.000324	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—IL6—hepatitis B	3.37e-05	0.000323	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—AKR1B1—hepatitis B	3.35e-05	0.000321	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HLA-A—hepatitis B	3.21e-05	0.000308	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GGT2—hepatitis B	3.21e-05	0.000308	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CTNNB1—hepatitis B	3.16e-05	0.000303	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—F2—hepatitis B	3.09e-05	0.000297	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.08e-05	0.000296	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CDKN1A—hepatitis B	3.08e-05	0.000296	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CCR5—hepatitis B	3.08e-05	0.000295	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—PTEN—hepatitis B	3.08e-05	0.000295	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—NFKB1—hepatitis B	3.06e-05	0.000294	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—IL6—hepatitis B	3.05e-05	0.000293	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CCR5—hepatitis B	3.04e-05	0.000292	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CCR5—hepatitis B	3.02e-05	0.000289	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GGT1—hepatitis B	2.98e-05	0.000286	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GOT1—hepatitis B	2.98e-05	0.000286	CbGpPWpGaD
Vemurafenib—RAF1—Disease—HLA-A—hepatitis B	2.97e-05	0.000284	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CDKN1A—hepatitis B	2.96e-05	0.000284	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	2.96e-05	0.000284	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—PTEN—hepatitis B	2.95e-05	0.000283	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—NFKB1—hepatitis B	2.94e-05	0.000282	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—HLA-A—hepatitis B	2.94e-05	0.000282	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—TLR4—hepatitis B	2.94e-05	0.000282	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HLA-DRB1—hepatitis B	2.93e-05	0.000282	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—F2—hepatitis B	2.9e-05	0.000278	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—TGFB1—hepatitis B	2.89e-05	0.000277	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	2.89e-05	0.000277	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—NOS2—hepatitis B	2.87e-05	0.000275	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—AKR1B1—hepatitis B	2.83e-05	0.000272	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—TGFB1—hepatitis B	2.83e-05	0.000272	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CD4—hepatitis B	2.76e-05	0.000265	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CXCL10—hepatitis B	2.75e-05	0.000264	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GGT2—hepatitis B	2.72e-05	0.000261	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—TNF—hepatitis B	2.7e-05	0.000259	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—F2—hepatitis B	2.64e-05	0.000254	CbGpPWpGaD
Vemurafenib—RAF1—Disease—NOS2—hepatitis B	2.58e-05	0.000247	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—NOS2—hepatitis B	2.56e-05	0.000245	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CTNNB1—hepatitis B	2.45e-05	0.000235	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CDKN1A—hepatitis B	2.4e-05	0.00023	CbGpPWpGaD
Vemurafenib—BRAF—Disease—PTEN—hepatitis B	2.39e-05	0.000229	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CYP2A6—hepatitis B	2.35e-05	0.000226	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—TP53—hepatitis B	2.33e-05	0.000224	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—AKR1B1—hepatitis B	2.19e-05	0.00021	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—IL6—hepatitis B	2.18e-05	0.000209	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IFNG—hepatitis B	2.14e-05	0.000206	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCR5—hepatitis B	2.13e-05	0.000204	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GOT2—hepatitis B	2.13e-05	0.000204	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GGT2—hepatitis B	2.1e-05	0.000201	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL2—hepatitis B	2.08e-05	0.0002	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD4—hepatitis B	2.07e-05	0.000199	CbGpPWpGaD
Vemurafenib—BRAF—Disease—TGFB1—hepatitis B	1.98e-05	0.00019	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—IL2—hepatitis B	1.95e-05	0.000188	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CYP2A6—hepatitis B	1.94e-05	0.000186	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—IL6—hepatitis B	1.92e-05	0.000184	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CD4—hepatitis B	1.91e-05	0.000183	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL2—hepatitis B	1.9e-05	0.000183	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CD4—hepatitis B	1.89e-05	0.000182	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CTNNB1—hepatitis B	1.84e-05	0.000176	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GOT1—hepatitis B	1.84e-05	0.000176	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GGT1—hepatitis B	1.84e-05	0.000176	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—F2—hepatitis B	1.83e-05	0.000175	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ALB—hepatitis B	1.8e-05	0.000173	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CDKN1A—hepatitis B	1.8e-05	0.000172	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—PTEN—hepatitis B	1.79e-05	0.000172	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—NFKB1—hepatitis B	1.78e-05	0.000171	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL2—hepatitis B	1.78e-05	0.000171	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GOT2—hepatitis B	1.76e-05	0.000169	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CTNNB1—hepatitis B	1.72e-05	0.000165	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CTNNB1—hepatitis B	1.7e-05	0.000163	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CTNNB1—hepatitis B	1.68e-05	0.000161	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CDKN1A—hepatitis B	1.68e-05	0.000161	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—PTEN—hepatitis B	1.67e-05	0.000161	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.67e-05	0.000161	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—NFKB1—hepatitis B	1.67e-05	0.00016	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CDKN1A—hepatitis B	1.66e-05	0.000159	CbGpPWpGaD
Vemurafenib—RAF1—Disease—PTEN—hepatitis B	1.65e-05	0.000159	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CYP2A6—hepatitis B	1.65e-05	0.000158	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CDKN1A—hepatitis B	1.64e-05	0.000158	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—PTEN—hepatitis B	1.64e-05	0.000157	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ALB—hepatitis B	1.58e-05	0.000152	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.53e-05	0.000147	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—TGFB1—hepatitis B	1.52e-05	0.000146	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GOT1—hepatitis B	1.52e-05	0.000146	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GGT1—hepatitis B	1.52e-05	0.000146	CbGpPWpGaD
Vemurafenib—BRAF—Disease—IL6—hepatitis B	1.49e-05	0.000143	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GOT2—hepatitis B	1.49e-05	0.000143	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TGFB1—hepatitis B	1.39e-05	0.000133	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PTEN—hepatitis B	1.37e-05	0.000132	CbGpPWpGaD
Vemurafenib—RAF1—Disease—TGFB1—hepatitis B	1.37e-05	0.000132	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—TGFB1—hepatitis B	1.36e-05	0.00013	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GGT1—hepatitis B	1.29e-05	0.000123	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GOT1—hepatitis B	1.29e-05	0.000123	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CYP2A6—hepatitis B	1.27e-05	0.000122	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—TP53—hepatitis B	1.26e-05	0.00012	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL2—hepatitis B	1.23e-05	0.000118	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL6—hepatitis B	1.22e-05	0.000118	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PTEN—hepatitis B	1.21e-05	0.000116	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CTNNB1—hepatitis B	1.19e-05	0.000114	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.17e-05	0.000112	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CDKN1A—hepatitis B	1.16e-05	0.000111	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PTEN—hepatitis B	1.16e-05	0.000111	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NFKB1—hepatitis B	1.15e-05	0.000111	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GOT2—hepatitis B	1.15e-05	0.00011	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TP53—hepatitis B	1.14e-05	0.00011	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL6—hepatitis B	1.12e-05	0.000107	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL6—hepatitis B	1.05e-05	0.0001	CbGpPWpGaD
Vemurafenib—RAF1—Disease—IL6—hepatitis B	1.03e-05	9.91e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—IL6—hepatitis B	1.02e-05	9.83e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GOT1—hepatitis B	9.92e-06	9.52e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GGT1—hepatitis B	9.92e-06	9.52e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TGFB1—hepatitis B	9.6e-06	9.21e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ALB—hepatitis B	8.07e-06	7.74e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TP53—hepatitis B	7.91e-06	7.58e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PTEN—hepatitis B	7.46e-06	7.15e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL6—hepatitis B	7.24e-06	6.94e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ALB—hepatitis B	6.84e-06	6.56e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PTEN—hepatitis B	6.16e-06	5.91e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ALB—hepatitis B	5.28e-06	5.06e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PTEN—hepatitis B	5.22e-06	5e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PTEN—hepatitis B	4.02e-06	3.86e-05	CbGpPWpGaD
